DJIA 17,279.74 13.75 0.08%
NASDAQ 4,579.79 -13.64 -0.30%
S&P 500 2,010.40 -0.96 -0.05%
market minute promo

4.16 -0.11 (-2.58%)

REAL-TIME: Last trade at

Extended Hours: $4.36 $0.20 (4.81%)
Quote as of (NASDAQ)



company name or ticker

Recent Quotes

ARNA $4.16 -2.58%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $4.29
Previous Close $4.27
Daily Range $4.16 - $4.74
52-Week Range $3.82 - $7.97
Market Cap $914.5M
P/E Ratio -16.42
Dividend (Yield) $0.00 (0.0%)
Volume 14,201,701
Average Daily Volume 4,012,238
Current FY EPS -$0.35

Sector

Healthcare

Industry

Drugs

Arena Pharmaceuticals, Inc. (ARNA) Description

A clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs in four major therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases. Website: http://www.arenapharm.com/

News & Commentary Rss Feed

3 Biotechs Investors Should Watch

The healthcare version of Where the Money Is.

Arena Pharmaceuticals, Inc. (ARNA) Jumps: Stock Rises 9.5% - Tale of the Tape

A Deeper Look At Belviq And Phentermine - Why Investors Need To Model Expectations

Arena Pharmaceuticals (ARNA) Flagged As Strong On High Volume

It Takes Less Than 15 Minutes To Buy VVUS Shares!

NASDAQ Biotech Top Performers (Pre-Open September 19)

Why VIVUS, Inc. Is Today's Best Biotech Stock

VIVUS stock is among today's top gainers after announcing the supplemental new drug approval for erectile dysfunction drug Stendra. Find out how this could impact VIVUS and its shareholders moving forward.

5 Things Arena Pharmaceuticals, Inc.'s Management Wants You to Know

Highlights from Arena Pharmaceuticals' conference call with investors.

Belviq And Phentermine Study Awes Some Investors - Should It?

Orexigen Therapeutics Wins Contrave Approval But Investors Should Stay Away

See More ARNA News...

ARNA's Top Competitors

ARNA $4.16 (-2.58%)
Current stock: ARNA
AMGN $144.01 (1.40%)
Current stock: AMGN
GILD $105.96 (0.03%)
Current stock: GILD
BIIB $329.24 (-0.23%)
Current stock: BIIB